Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Colonna

Showing results (261-270 of 525) with videos related to

Pageof 53
Sort By:
Nature Immunology|June 26, 2012
IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microgliaYaming Wang, Kristy J Szretter, William Vermi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 14, 2016
Alzheimer's disease-associated TREM2 variants exhibit either decreased or increased ligand-dependent activationWilbur Song, Basavaraj Hooli, Kristina Mullin, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|December 20, 2015
TREM-1-accentuated lung injury via miR-155 is inhibited by LP17 nanomedicineZhihong Yuan, Mansoor Syed, Dipti Panchal, et al.
Scientific Reports|May 19, 2019
Aminophospholipids are signal-transducing TREM2 ligands on apoptotic cellsKeiro Shirotani, Yuma Hori, Ryohei Yoshizaki, et al.
The Journal of Experimental Medicine|July 1, 2009
Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvantM Paula Longhi, Christine Trumpfheller, Juliana Idoyaga, et al.
Therapeutic Advances in Infectious Disease|May 12, 2025
Recombinant interleukin-7 treatment of refractory <i>Mycobacterium avium</i> complex lung disease (IMPULSE-7): a pilot phase II, single-center, randomized, clinical trialCarlos Mejia-Chew, Andrej Spec, Andrew H Walton, et al.
Life Science Alliance|October 28, 2024
Targeting TREM2 signaling shows limited impact on cerebrovascular calcificationSucheta Sridhar, Yingyue Zhou, Adiljan Ibrahim, et al.
The Journal of Experimental Medicine|September 3, 2014
Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus modelSarah L Rowland, Jeffrey M Riggs, Susan Gilfillan, et al.
Blood|December 14, 2002
Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C/E and NKD2D killer cell receptorsValerie Bigouret, Till Hoffmann, Lionel Arlettaz, et al.
The Journal of Experimental Medicine|June 8, 2021
Activated microglia mitigate Aβ-associated tau seeding and spreadingMaud Gratuze, Yun Chen, Samira Parhizkar, et al.
Pageof 53

Showing results (261-270 of 525) with videos related to

Sort By:
Pageof 53
Nature Immunology|June 26, 2012
IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microgliaYaming Wang, Kristy J Szretter, William Vermi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 14, 2016
Alzheimer's disease-associated TREM2 variants exhibit either decreased or increased ligand-dependent activationWilbur Song, Basavaraj Hooli, Kristina Mullin, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|December 20, 2015
TREM-1-accentuated lung injury via miR-155 is inhibited by LP17 nanomedicineZhihong Yuan, Mansoor Syed, Dipti Panchal, et al.
Scientific Reports|May 19, 2019
Aminophospholipids are signal-transducing TREM2 ligands on apoptotic cellsKeiro Shirotani, Yuma Hori, Ryohei Yoshizaki, et al.
The Journal of Experimental Medicine|July 1, 2009
Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvantM Paula Longhi, Christine Trumpfheller, Juliana Idoyaga, et al.
Therapeutic Advances in Infectious Disease|May 12, 2025
Recombinant interleukin-7 treatment of refractory <i>Mycobacterium avium</i> complex lung disease (IMPULSE-7): a pilot phase II, single-center, randomized, clinical trialCarlos Mejia-Chew, Andrej Spec, Andrew H Walton, et al.
Life Science Alliance|October 28, 2024
Targeting TREM2 signaling shows limited impact on cerebrovascular calcificationSucheta Sridhar, Yingyue Zhou, Adiljan Ibrahim, et al.
The Journal of Experimental Medicine|September 3, 2014
Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus modelSarah L Rowland, Jeffrey M Riggs, Susan Gilfillan, et al.
Blood|December 14, 2002
Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C/E and NKD2D killer cell receptorsValerie Bigouret, Till Hoffmann, Lionel Arlettaz, et al.
The Journal of Experimental Medicine|June 8, 2021
Activated microglia mitigate Aβ-associated tau seeding and spreadingMaud Gratuze, Yun Chen, Samira Parhizkar, et al.
Pageof 53